Houston, TX, United States of America

Angus Wilfong


 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 121(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Angus Wilfong

Introduction

Angus Wilfong, a notable inventor based in Houston, TX, has made significant contributions to the field of medical treatments, especially in the use of cannabinoids. With two registered patents to his name, his work primarily focuses on addressing the challenges associated with treatment-resistant epilepsy.

Latest Patents

Wilfong's latest patents highlight the therapeutic potential of cannabidiol (CBD) in reducing the frequency of convulsive seizures. The disclosures particularly emphasize the application of CBD for treating treatment-resistant epilepsy (TRE), specifically in cases like Dravet syndrome, myoclonic absence seizures, and febrile infection-related epilepsy syndrome (FIRES). Additionally, his research explores the use of CBD in conjunction with other anti-epileptic drugs (AEDs), showcasing the innovative approaches he is taking towards epilepsy treatment.

Career Highlights

Angus Wilfong's career is marked by his dedication to advancing medical therapies through innovation. His work within Gw Pharma Limited demonstrates his commitment to developing effective treatments for patients who struggle with epilepsy. The contributions he has made to cannabinoid research have the potential to change therapeutic practices and improve the quality of life for many individuals.

Collaborations

Throughout his career, Wilfong has collaborated with esteemed colleagues such as Geoffrey W Guy and Stephen Wright. Together, they have worked on pioneering approaches to harnessing the medicinal properties of cannabinoids, underscoring the importance of teamwork in pushing the boundaries of scientific inquiry and innovation.

Conclusion

Angus Wilfong stands out as an influential figure in the realm of cannabinoid research and epilepsy treatment. His patents not only reflect his innovative spirit but also represent a significant advancement in medical science, offering hope to those affected by severe forms of epilepsy. Through his efforts at Gw Pharma Limited, along with his collaborative work, Wilfong continues to contribute meaningfully to the landscape of medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…